David Mitchell, a multiple myeloma patient, has been paying exorbitant amounts for his needed medication. This led him to found the advocacy group Patients for Affordable Drugs, which in part was instrumental in getting drug price reforms into the 2022 Inflation Reduction Act. The changes implemented by this act have led to significant savings for individuals like Mitchell and many other Medicare beneficiaries. The act also represents a significant overhaul for the U.S. drug marketplace. However, there have been responses from pharmaceutical companies including lawsuits to stop negotiation over drug prices. Additionally, other legislation and efforts from the Biden administration aim to complement current efforts to lower drug prices.
Source link
Patients See First Savings From Biden’s Drug Price Push, as Pharma Lines Up Its Lawyers
